TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21450118

Group type: EXPERIMENTAL
Intervention: 4 × 240 ml black tea providing 168 mg of caffeine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 6 × 240 ml black tea providing 252 mg of caffeine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Boiled water (control)
Number of subjects: 21
Study: 19084784

Group type: EXPERIMENTAL
Intervention: Web-based game
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-study computerized flash cards
Number of subjects: 0
Study: 17473069

Group type: EXPERIMENTAL
Intervention: Lower dose L‐T4 (subclinical hypothyroid arm)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Usual dose L‐T4 (euthyroid arm)
Number of subjects: 19
Study: 15033503

Group type: EXPERIMENTAL
Intervention: Feedback framing positive social cues
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Feedback framing absence of negative outcomes
Number of subjects: 64
Study: 11392571

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate Diskus inhaler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Budesonide Turbuhaler inhaler
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diskus inhaler
Number of subjects: 0
Study: 9677446

Group type: EXPERIMENTAL
Intervention: Pre-operative radiation therapy followed by cystectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cystectomy alone
Number of subjects: 0
Study: 7932278

Group type: EXPERIMENTAL
Intervention: Alprazolam treatment over 8 weeks
Number of subjects: 2

Group type: COMPARATOR
Intervention: Normal women in the premenstrual phase
Number of subjects: 2
Study: 3051870

Group type: EXPERIMENTAL
Intervention: Vabra mc cervix
Number of subjects: 298

Group type: COMPARATOR
Intervention: Conventional curettage
Number of subjects: 298
Study: 29024081

Group type: EXPERIMENTAL
Intervention: Rosa canina fruit capsules (500 mg, twice daily for 20 days)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 400
Study: 27138026

Group type: EXPERIMENTAL
Intervention: FDC1 (amlodipine/rosuvastatin 10mg/20mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: FDC2 (amlodipine/rosuvastatin 10mg/20mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference tablets (coadministered commercially available amlodipine and rosuvastatin)
Number of subjects: 24
Study: 23959379

Group type: EXPERIMENTAL
Intervention: Fluoroscopic guidance
Number of subjects: 609

Group type: COMPARATOR
Intervention: Anatomic method
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 609
Study: 22639864

Group type: EXPERIMENTAL
Intervention: Semi-rigid ankle brace
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tape
Number of subjects: 100
Study: 20416041

Group type: EXPERIMENTAL
Intervention: Low glycaemic index carbohydrate diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: No dietary intervention
Number of subjects: 0
Study: 20664147

Group type: EXPERIMENTAL
Intervention: WHEE (the wholistic hybrid derived from EMDR and EFT), n=50
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (beyond the 15‐ to 18‐foot range of the healer's EM heart field), n=41
Number of subjects: 91
Study: 15844319

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) injection (10 microg/d for 10 days in one month, for a total of 6 months)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no PGE1, same other therapy)
Number of subjects: 24
Study: 12236411

Group type: EXPERIMENTAL
Intervention: Psychoeducation Responsive to Family (PERF) model
Number of subjects: 19

Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 19
Study: 10403876

Group type: EXPERIMENTAL
Intervention: Cerebral palsy not taking anticonvulsant medication
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cerebral palsy taking anticonvulsant medication
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (children without cerebral palsy)
Number of subjects: 29
Study: 7738506

Group type: EXPERIMENTAL
Intervention: Inconsistent condition (reading sentences where the object was inconsistent with the protagonist's location)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mention of an object by means of an ambiguous pronoun
Number of subjects: 0

Group type: COMPARATOR
Intervention: No specific intervention mentioned
Number of subjects: 0
Study: 2160343

Group type: EXPERIMENTAL
Intervention: Low sodium, cholesterol lowering diet (less than 60 mmol/day sodium, 30% energy from fat, high P/S ratio, 30-50 g/day fibre)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Low sodium, cholesterol maintaining diet (less than 60 mmol/day sodium)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Sodium restriction
Number of subjects: 95

Group type: COMPARATOR
Intervention: Sodium supplement (100 mmol/day NaCl)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 432540

Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy (PCV)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Selective vagotomy with pyloroplasty (SV + P)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (gastric resection)
Number of subjects: 37
Study: 29986150

Group type: COMPARATOR
Intervention: 5 days of MCT alone (30 g·day‐1)
Number of subjects: 19

Group type: COMPARATOR
Intervention: 1 session of 30 min of AE alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 5 days of MCT and AE combined (MCT+AE)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 19
Study: 29021908

Group type: EXPERIMENTAL
Intervention: Fustra20Neck&Back exercise program, individually guided neuromuscular exercise twice weekly for 10 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25546379

Group type: EXPERIMENTAL
Intervention: Low-dose active (LDA) group: 500 mg of flaxseed hull extract containing 100 mg of secoisolariciresinol diglucoside (SDG), n=26
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose active (HDA) group: 1000 mg of flaxseed hull extract containing 200 mg of secoisolariciresinol diglucoside (SDG), n=26
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (P) group: matching maltodextrin capsules, n=28
Number of subjects: 60
Study: 23322362

Group type: EXPERIMENTAL
Intervention: Teriparatide (20 μg/d)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Risedronate (35 mg/week)
Number of subjects: 92
Study: 21301382

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (1.25 mg/0.05 mL) every 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Observation (Control Group)
Number of subjects: 20
Study: 19593148

Group type: EXPERIMENTAL
Intervention: Laryngopharyngeal Examination blade
Number of subjects: 81

Group type: COMPARATOR
Intervention: English Macintosh blade
Number of subjects: 81
Study: 17717918

Group type: EXPERIMENTAL
Intervention: Jianwei Yuyang Granule (JYG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Famotidine and sucralfate (Control)
Number of subjects: 56
Study: 15156385

Group type: EXPERIMENTAL
Intervention: Minilaparoscopy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Computed Tomography (CT)
Number of subjects: 56
Study: 11846050

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 610

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 610
Study: 9842609

Group type: EXPERIMENTAL
Intervention: LSD ingestion
Number of subjects: 3

Group type: COMPARATOR
Intervention: Stationary magnets or removal of apparatus
Number of subjects: 3
Study: 8042331

Group type: EXPERIMENTAL
Intervention: Endoscopic variceal sclerotherapy (EVS)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Distal splenorenal shunt (DSRS)
Number of subjects: 149
Study: 2635350

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (ABM) 1.5 mg.kg-1
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (ABM) 2.25 mg.kg-1
Number of subjects: 26

Group type: COMPARATOR
Intervention: Almitrine bismesylate (ABM) 0.75 mg.kg-1
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 370525

Group type: EXPERIMENTAL
Intervention: Bromocriptine (5 mg per day) during the luteal phase
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 8
Study: 30866856

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA‐α) injection (0.45 μg/kg once weekly subcutaneously)
Number of subjects: 126

Group type: COMPARATOR
Intervention: EPO (50 IU/kg thrice weekly subcutaneously)
Number of subjects: 126
Study: 28100192

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 3075

Group type: COMPARATOR
Intervention: Other basal insulin regimens
Number of subjects: 3075
Study: 27190323

Group type: EXPERIMENTAL
Intervention: Emapticap (0.5 mg/kg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Emapticap
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Emapticap (post hoc analysis)
Number of subjects: 75
Study: 24642133

Group type: EXPERIMENTAL
Intervention: Intermaxillary fixation screw (IMFS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Eyelet interdental wiring
Number of subjects: 50
Study: 23093099

Group type: EXPERIMENTAL
Intervention: Educational intervention based on health promotion model (HPM)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 165
Study: 19398783

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (enoxaparin)
Number of subjects: 440

Group type: COMPARATOR
Intervention: No prophylaxis (control)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings (GCS)
Number of subjects: 440
Study: 17966757

Group type: EXPERIMENTAL
Intervention: Amiodarone 200 mg tablet with food
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amiodarone 200 mg tablet without food
Number of subjects: 0
Study: 15554767

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Perospirone
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional antipsychotic drugs
Number of subjects: 92
Study: 14588350

Group type: EXPERIMENTAL
Intervention: Instrumented posterior lumbar interbody fusion (PLIF)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Nonoperative management (spinal extensor muscle-strengthening exercise, medications, and restricted duty)
Number of subjects: 29
Study: 9636566

Group type: EXPERIMENTAL
Intervention: Neoral (cyclosporine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prograf (tacrolimus)
Number of subjects: 0
Study: 7512336

Group type: EXPERIMENTAL
Intervention: Krypton laser treatment for AMD
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Krypton laser treatment for ocular histoplasmosis
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Krypton laser treatment for idiopathic choroidal neovascularization
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Krypton laser treatment for normotensive patients with AMD
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Krypton laser treatment for hypertensive patients with AMD
Number of subjects: 300
Study: 2974719

Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide gel (Benzac W5)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1% clindamycin phosphate solution (Cleocin T)
Number of subjects: 0
Study: 29555214

Group type: EXPERIMENTAL
Intervention: Patients with schizophrenia experiencing MI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Schizophrenia controls (experiencing MI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MI controls (general population experiencing MI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls not experiencing MI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with schizophrenia
Number of subjects: 0

Group type: COMPARATOR
Intervention: MI controls
Number of subjects: 0
Study: 28485467

Group type: EXPERIMENTAL
Intervention: Dynamic Needle Tip Positioning (DNTP) ultrasound technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Palpation technique
Number of subjects: 50
Study: 26168743

Group type: EXPERIMENTAL
Intervention: Methocarbamol (Ortoton), orally administered for up to 8 days
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Methocarbamol (Ortoton)
Number of subjects: 202
Study: 23972027

Group type: EXPERIMENTAL
Intervention: Caregiver training intervention
Number of subjects: 0
Study: 21347990

Group type: EXPERIMENTAL
Intervention: Following another person making deliberate skin‐crossing saccades between the outside area and the tumour from multiple angles
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Following another person making natural skin‐crossing saccades between the outside area and the tumour from multiple angles
Number of subjects: 150

Group type: COMPARATOR
Intervention: Focusing solely on the central tumour
Number of subjects: 150
Study: 18355507

Group type: EXPERIMENTAL
Intervention: Intravenous cariporide (180 mg in a 1-hour preoperative loading dose, then 40 mg per hour over 24 hours and 20 mg per hour over the subsequent 24 hours)
Number of subjects: 5761

Group type: EXPERIMENTAL
Intervention: Intravenous cariporide
Number of subjects: 5761

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5761
Study: 16328116

Group type: EXPERIMENTAL
Intervention: Monarc
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sparc
Number of subjects: 60
Study: 12609781

Group type: EXPERIMENTAL
Intervention: Lymecycline 300 mg od
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Lymecycline 150 mg bid
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study: 15184612

Group type: EXPERIMENTAL
Intervention: 3,4-diaminopyridine (3,4-DAP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10396008

Group type: EXPERIMENTAL
Intervention: Combined treatment (pharmacotherapy + cognitive‐behavioral psychotherapy)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 26
Study: 7555472

Group type: EXPERIMENTAL
Intervention: Combination group (insulin + OHAs)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Insulin group (insulin alone)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 2100046

Group type: EXPERIMENTAL
Intervention: Apomorphine (different doses, subcutaneously)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 395630

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g intravenously six times daily for a maximum of 3 days, followed by 1.5 g orally four times daily for a maximum of 4 days)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 149
Study: 28942691

Group type: EXPERIMENTAL
Intervention: Transvaginal cervical length measurement at 16-20 weeks gestation
Number of subjects: 178
Study: 28045793

Group type: EXPERIMENTAL
Intervention: Intervention units received unit-level violence data to facilitate development of an action plan for violence prevention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control units received no data
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intervention units received unit-level violence data
Number of subjects: 41
Study: 25964070

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg daily
Number of subjects: 1791

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg daily
Number of subjects: 1791

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg and 8 mg daily
Number of subjects: 1791
Study: 23563932

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vitamin D use
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no ADT)
Number of subjects: 80
Study: 21271509

Group type: EXPERIMENTAL
Intervention: Single stage TKA
Number of subjects: 78

Group type: COMPARATOR
Intervention: Two-stage TKA
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Stolzalpen knee score
Number of subjects: 78
Study: 19166691

Group type: COMPARATOR
Intervention: Ezetimibe 10 mg/day (monotherapy)
Number of subjects: 5261

Group type: COMPARATOR
Intervention: Ezetimibe 10 mg/day (add-on to statin therapy)
Number of subjects: 5261
Study: 17952525

Group type: COMPARATOR
Intervention: Lichtenstein mesh hernioplasty (LMH)
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Moloney darn repair (MDR)
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Both MDR and LMH
Number of subjects: 651
Study: 15485009

Group type: EXPERIMENTAL
Intervention: TAMMEF (Therapeutic Application of a Musically Modulated Electromagnetic Field)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: ELF (Extremely Low Frequencies)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Simulated field (Control group)
Number of subjects: 90
Study: 11295785

Group type: EXPERIMENTAL
Intervention: lisuride
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 9174320

Group type: EXPERIMENTAL
Intervention: Train-of-four (TOF) stimulation
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Double burst stimulation (DBS3,3)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Double burst stimulation (DBS3,2)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Baseline displacement measurement
Number of subjects: 105
Study: 7947499

Group type: EXPERIMENTAL
Intervention: Intermittent electronic fetal monitoring (I-group)
Number of subjects: 4044

Group type: COMPARATOR
Intervention: Continuous electronic fetal monitoring (C-group)
Number of subjects: 4044

Group type: EXPERIMENTAL
Intervention: Both groups (I-group and C-group)
Number of subjects: 4044
Study: 29634656

Group type: EXPERIMENTAL
Intervention: Prolastin C, plasma-derived AAT, at 60 mg/kg infused intravenously within 12 hours of reperfusion
Number of subjects: 10
Study: 27513506

Group type: EXPERIMENTAL
Intervention: Plant sterols (2.24 g daily) in skim milk (350 ml twice daily) for 3 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group received the same amount of skim milk without plant sterols
Number of subjects: 54
Study: 25534171

Group type: EXPERIMENTAL
Intervention: Intervention group (n=166)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control group (n=184)
Number of subjects: 350
Study: 23038067

Group type: EXPERIMENTAL
Intervention: Continuous pain registration procedure using electronic VAS
Number of subjects: 28
Study: 20518266

Group type: EXPERIMENTAL
Intervention: Prolene mesh (anterior and posterior prolift)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Sacrospinous fixation
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: All surgical techniques (including Prolene mesh and sacrospinous fixation)
Number of subjects: 500
Study: 18384590

Group type: EXPERIMENTAL
Intervention: Care manager home environment assessment
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Linking caregivers to community agencies for nonspecific needs
Number of subjects: 238

Group type: COMPARATOR
Intervention: No specific care management activities
Number of subjects: 238
Study: 16554145

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg the day before and 1200 mg on race day)
Number of subjects: 54
Study: 12610048

Group type: COMPARATOR
Intervention: Neither diabetes nor NF-CVD
Number of subjects: 11645

Group type: EXPERIMENTAL
Intervention: Diabetes only
Number of subjects: 11645

Group type: EXPERIMENTAL
Intervention: NF-CVD only
Number of subjects: 11645

Group type: EXPERIMENTAL
Intervention: Both diabetes and NF-CVD
Number of subjects: 11645

Group type: EXPERIMENTAL
Intervention: NF-CVD
Number of subjects: 11645

Group type: EXPERIMENTAL
Intervention: Participants on hypoglycemic agents
Number of subjects: 11645
Study: 10771455

Group type: EXPERIMENTAL
Intervention: Ziprasidone 40 mg + Cimetidine 800 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ziprasidone 40 mg + Maalox
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ziprasidone 40 mg alone
Number of subjects: 11
Study: 9238880

Group type: EXPERIMENTAL
Intervention: Plaq & White125 electric toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral‐B 35 manual toothbrush (Control)
Number of subjects: 0
Study: 1450081

Group type: EXPERIMENTAL
Intervention: Standard protocol treatment
Number of subjects: 14315

Group type: COMPARATOR
Intervention: Randomized trials
Number of subjects: 14315

Group type: COMPARATOR
Intervention: Standard protocol (non-randomized)
Number of subjects: 14315
Study: 2413686

Group type: EXPERIMENTAL
Intervention: Benoxaprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30172030

Group type: EXPERIMENTAL
Intervention: Proprioceptive identification of joint position (first experiment)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Kinaesthetic movement reproduction (second experiment)
Number of subjects: 30
Study: 26852885

Group type: EXPERIMENTAL
Intervention: Combined training (6 resistance exercises + 30 min aerobic exercise, 3 days/week for 12 weeks)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined training
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (overweight girls, no intervention)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Normal-weight group (n=15)
Number of subjects: 33
Study: 24886382

Group type: EXPERIMENTAL
Intervention: New rehabilitation programme (structured goal-planning, motivational interviewing, self-help booklet, four follow-up telephone calls during the first five months)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: New rehabilitation programme
Number of subjects: 6

Group type: COMPARATOR
Intervention: Current traditional rehabilitation programme
Number of subjects: 6
Study: 22614776

Group type: EXPERIMENTAL
Intervention: Therapist assisted by a computer
Number of subjects: 726

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 726
Study: 20305509

Group type: EXPERIMENTAL
Intervention: Intubation for 2 months (group I, 48 eyes)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Intubation for 5 months (group II, 47 eyes)
Number of subjects: 145
Study: 18376061

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57